TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
JK Biostatistics AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 2,882 | 2,806 | 2,595 |
Financial expenses | 1 | 3 | 0 |
Earnings before taxes | 155 | 516 | 724 |
EBITDA | 188 | 519 | 668 |
Total assets | 2,155 | 1,448 | 1,415 |
Current assets | 1,753 | 1,267 | 300 |
Current liabilities | 757 | 241 | 331 |
Equity capital | 1,398 | 1,207 | 1,084 |
- share capital | 101 | 95 | 98 |
Employees (average) | 3 | 3 | 2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 64.9% | 83.4% | 76.6% |
Turnover per employee | 961 | 935 | 1,298 |
Profit as a percentage of turnover | 5.4% | 18.4% | 27.9% |
Return on assets (ROA) | 7.2% | 35.8% | 51.2% |
Current ratio | 231.6% | 525.7% | 90.6% |
Return on equity (ROE) | 11.1% | 42.8% | 66.8% |
Change turnover | -123 | 289 | 136 |
Change turnover % | -4% | 11% | 6% |
Chg. No. of employees | 0 | 1 | 0 |
Chg. No. of employees % | 0% | 50% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.